RENAL DENERVATION MODULE
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

RENAL DENERVATION MODULE Trademark

Serial Number: 99665013

RENAL DENERVATION MODULE is a trademark filed by American College of Cardiology Foundation on February 23, 2026. The trademark is classified under Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

American College of Cardiology Foundation

2400 N Street, N.W.
Washington, DC 20037

Entity Type: 99

Trademark Details

Filing Date

February 23, 2026

Registration Date

Not Registered

Goods & Services

Providing online registries featuring quality assurance measurement, performance benchmarking, utilization tracking, and outcomes assessment in the fields of medicine, healthcare, cardiovascular care, vascular care, interventional procedures, and disease management as they relate to hypertension or high blood pressure

Providing nondownloadable software for collecting, aggregating, monitoring, analyzing, reporting, benchmarking, and exporting healthcare, medical, and clinical data, including patient outcomes, procedural outcomes, treatment utilization, and medical device data, for use in quality improvement, research, regulatory reporting, and healthcare operations, all in the fields of medicine, healthcare, cardiovascular care, vascular care, interventional procedures, and disease management as they relate to hypertension or high blood pressure; providing software and software applications for real-world evidence generation and monitoring, namely, site-level, regional-level, and national-level monitoring, cohort analysis, longitudinal tracking, and comparison against benchmark datasets, all in the fields of medicine, healthcare, cardiovascular care, vascular care, interventional procedures, and disease management as they relate to hypertension or high blood pressure; providing software and software applications for supporting clinical research, post-market surveillance, post-approval studies, and evidence development for medical procedures, therapies, and devices, all in the fields of medicine, healthcare, cardiovascular care, vascular care, interventional procedures, and disease management as they relate to hypertension or high blood pressure; providing quality assurance measurement and outcomes assessment services for hospitals, physicians, healthcare facilities, and research organizations in the fields of medicine, healthcare, cardiovascular care, vascular care, interventional procedures, and disease management as they relate to hypertension or high blood pressure

Filing History

APPLICATION FILING RECEIPT MAILED
Feb 23, 2026 MAFR
NEW APPLICATION ENTERED
Feb 23, 2026 NWAP